Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-04-26

Clinical Trial Update: Amoxicillin for Enteral Nutrition Intolerance in Pediatric Intensive Care Unit [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update exploring amoxicillin for enteral nutrition intolerance in pediatric ICU (Phase 2 and Phase 3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMOXICILLIN (AMOXICILLIN)

Snippet

Sponsor: Sohag University | Conditions: Enteral Feeding Intolerance | Phase 2, Phase 3 | Status: UNKNOWN